Literature DB >> 23241969

Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally.

Catherine A Ison1, Daniel Golparian, Pamela Saunders, Stephanie Chisholm, Magnus Unemo.   

Abstract

OBJECTIVES: Identification of genetic targets specific to Neisseria gonorrhoeae for use in molecular detection methods has been a challenge. The porA pseudogene in N gonorrhoeae has been commonly used but recently gonococcal isolates giving a negative result in these PCRs have been reported. Here we describe the characterisation of two such gonococcal isolates received by the reference service at the Health Protection Agency, London, England.
METHODS: Phenotypic characterisation was achieved using conventional biochemical and immunological tests, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS), antimicrobial susceptibility testing, serovar determination and detection of meningococcal PorA using monoclonal antibody 4BG4-E7. Genetic species confirmation was determined using commercial and in house PCRs and 16S rRNA gene sequencing. Molecular typing using the N gonorrhoeae multi-antigen sequence typing (NG-MAST) and multilocus sequence typing (MLST) was performed. The DNA sequence of the full-length gonococcal porA pseudogene was determined and compared with published sequences.
RESULTS: Both isolates were confirmed, biochemically and immunologically as N gonorrhoeae, but repeatedly gave negative results with two in house real-time PCR assays for the porA pseudogene. Further characterisation of these isolates identified the presence of a meningococcal porA sequence and showed these isolates belong to serovar Bropyst, and to NG-MAST sequence type (ST) 5967 and MLST ST1901.
CONCLUSIONS: Gonococcal isolates that give false negative results with porA pseudogene PCR assays have now been identified in four countries, three of which are in Europe, and do not appear clonal. This report highlights the genetic diversity of N gonorrhoeae, which remains a challenge for the molecular detection methods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241969     DOI: 10.1136/sextrans-2012-050829

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  14 in total

1.  Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.

Authors:  Daniel Golparian; Stina Boräng; Martin Sundqvist; Magnus Unemo
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

2.  The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.

Authors:  Magnus Unemo; Daniel Golparian; Leonor Sánchez-Busó; Yonatan Grad; Susanne Jacobsson; Makoto Ohnishi; Monica M Lahra; Athena Limnios; Aleksandra E Sikora; Teodora Wi; Simon R Harris
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

3.  Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  Sepehr N Tabrizi; Magnus Unemo; Daniel Golparian; Jimmy Twin; Athena E Limnios; Monica Lahra; Rebecca Guy
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

Review 4.  Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae.

Authors:  Tatum D Mortimer; Yonatan H Grad
Journal:  Ann N Y Acad Sci       Date:  2018-06-06       Impact factor: 5.691

5.  Gonorrhoea Diagnostic and Treatment Uncertainties: Risk Factors for Culture Negative Confirmation after Positive Nucleic Acid Amplification Tests.

Authors:  Rebecka Vyth; Amy Leval; Björn Eriksson; Eva-Lena Ericson; Lena Marions; Maria-Pia Hergens
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

6.  Recorded gonorrhoea rates in Denmark, 1900-2010: the impact of clinical testing activity and laboratory diagnostic procedures.

Authors:  Inga Lind; Steen Hoffmann
Journal:  BMJ Open       Date:  2015-11-30       Impact factor: 2.692

7.  Finnish new variant of Chlamydia trachomatis escaping detection in the Aptima Combo 2 assay also present in Örebro County, Sweden, May 2019.

Authors:  Magnus Unemo; Marit Hansen; Ronza Hadad; Ylva Lindroth; Hans Fredlund; Mirja Puolakkainen; Martin Sundqvist
Journal:  Euro Surveill       Date:  2019-06

Review 8.  The Laboratory Diagnosis of Neisseria gonorrhoeae: Current Testing and Future Demands.

Authors:  Thomas Meyer; Susanne Buder
Journal:  Pathogens       Date:  2020-01-31

9.  Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications.

Authors:  Taylor Mae Oeschger; David Carl Erickson
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

10.  Genetic determinants of genus-level glycan diversity in a bacterial protein glycosylation system.

Authors:  Chris Hadjineophytou; Jan Haug Anonsen; Nelson Wang; Kevin C Ma; Raimonda Viburiene; Åshild Vik; Odile B Harrison; Martin C J Maiden; Yonatan H Grad; Michael Koomey
Journal:  PLoS Genet       Date:  2019-12-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.